Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical

Public Plan As Fallback Gaining Traction? Daschle Blueprint May Be In Play

  • News

Executive Summary

Health reform discussions in Washington are giving more attention to the idea of having a government-run insurance plan as a fallback option, providing a compromise on the contentious public plan issue
Table

View full table

Advertisement

Related Content

Pink Sheet
Postmarketing Studies Face Continued Scrutiny Despite Cleaned-Up Database
Pink Sheet
Postmarketing Studies Face Continued Scrutiny Despite Cleaned-Up Database
Pink Sheet
Public Plan Consensus Possible? Daschle Offers A “Qualified Yes”
Pink Sheet
Public Plan Consensus Possible? Daschle Offers A “Qualified Yes”

Topics

Advertisement
Tags:
BioPharmaceutical
UsernamePublicRestriction

Register

PS051463

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By